Refine by
Liver Fibrosis Articles & Analysis
10 articles found
Alterations in serum N-glycan profiles now serve as early detection biomarkers for liver fibrosis, outperforming traditional markers. Meanwhile, aberrant O-glycosylation in mucins creates the CA125 epitope used to monitor ovarian cancer progression. ...
Such models allow for controlled studies in vitro, facilitating the examination of cellular mechanisms, lipid metabolism, and the effects of specific compounds on liver cells. They serve as an excellent tool for screening potential drugs or understanding the effects of dietary components on liver health. ...
These mRNA-loaded LNPs deliver specific mRNA to the liver for the treatment of various liver-related diseases, including infectious diseases, liver fibrosis, cancer, and genetic disorders. 2) Spleen or lung targeting LNP: Researchers at the University of Texas Southwestern Medical Center reported that selective organ targeting ...
Biliary disease is a term used to describe diseases that affect the biliary system, which can result in inflammation, fibrosis, bile duct destruction, and eventually liver failure. It also frequently leads to secondary infections and chronic irritation, such as bile duct stones, which can lead to malignant tumors. ...
A total of 44% of patients had no improvement in liver stiffness despite achieving SVR. In patients with advanced fibrosis (lower level of albumin [Alb] or histological fibrosis stage F4), it was difficult to improve liver stiffness. Except for Alb, there were no blood tests associated with nonimprovement in ...
These risk factors can easily lead to liver damage, which subsequently develops into liver fibrosis, cirrhosis and eventually liver cancer. ...
This important study of MRE and long term cardiovascular outcomes adds a new dimension to the growing body of literature that elevated liver stiffness is not only correlated with increased liver fibrosis and adverse liver-related events, but is tied to adverse systemic events as well. To read the full study: ...
The liver plays an incredibly important role in the human body by metabolizing drugs and other compounds. ...
Furthermore, stool bile acids and propionate are elevated, especially in non-obese subjects with significant fibrosis. Fibrosis-relatedRuminococcaceaeandVeillonellaceaespecies undergo metagenome sequencing, and four representative species are administered in three mouse NAFLD models to evaluate their effects on liver damage. This study provides ...
Evaluation of potential antifibrotic therapies are limited using conventional non-human animal models, due to their inability to accurately reflect complex in vivo human biology, while 2D models lack the multicellular complexity and life span required to study fibrosis progression and regression. Utilization of a human 3D-bioprinted liver tissue model ...